Search Results 131-140 of 1304 for ☃휴대폰소액결제현금화 (010-9675-8884) 카톡 ON8884 콘텐츠이용료소액결제☃

  1. Evaluation of PCLs Using Three EUS-FNA Needles - Mayo Clinic

    About this study. To document impact of EUS-FNA needle size and flexibility on effectiveness of pancreatic cystic lesions (PCL) aspiration, on ability to ...

  2. A Study to Assess the Safety and Tolerability of CFT8634 in Locally Advanced or Metastatic SMARCB1-Perturbed Cancers, Including Synovial Sarcoma and SMARCB1-Null Tumors - Mayo Clinic

    Phase 2 only: To assess preliminary antitumor activity by overall response rate (ORR) as measured by Response Evaluation Criteria in Solid Tumors (RECIST) v1.1 ...

  3. Study of SC-003 in Subjects With Platinum-Resistant/Refractory Ovarian Cancer - Mayo Clinic

    SC-003 is an antibody-drug conjugate (ADC) comprised of a monoclonal antibody linked to a potent chemotherapy. Participation eligibility. Participant ...

  4. A Study of Autoimmune Functions in Patients with Myocarditis - Mayo Clinic

    About this study. The purpose of this research is to study immune cells called T cells and monocytes (types of blood cells that fight infection and can also ...

  5. An Extension Study to Assess Long-Term Safety of Eplontersen in Adults with Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM) - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  6. Safety Study of VAL-083 in Patients with Recurrent Malignant Glioma - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  7. A Study to Evaluate Direct Measurement of Proinsulin Clearance in Humans - Mayo Clinic

    The purpose of this study is to determine if changes in fasting glucose and FFA concentrations alter 1st phase insulin secretion and proinsulin secretion in non ...

  8. Phase 2 Placebo-Controlled, Double-Blind, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of DCR-PHXC Solution for Injection (subcutaneous use) in Patients with Primary Hyperoxaluria - PHYOX 2 - Mayo Clinic

    Phase 2 Placebo-Controlled, Double-Blind, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of DCR-PHXC Solution for Injection (subcutaneous ...

  9. Application for Self-Monitoring of Cardiovascular Risk - Mayo Clinic

    About this study. Patients who recently suffered a heart attack will use a smart-phone/computer application during cardiac rehabilitation to reduce their ...

  10. Dose Escalation Study of Safety and Tolerability of AT-406 in Patients With Advanced Solid Tumors and Lymphomas - Mayo Clinic

    About this study. The purpose of this study is to determine the safety profile and the maximum dose of Debio 1143 (AT-406) that can be given to humans.